Uganda introduces long-acting lenacapavir for HIV prevention
Uganda’s Ministry of Health is set to initiate the rollout of long-acting injectable lenacapavir for HIV prevention, beginning at Lira Regional Referral Hospital. The introduction follows 2025 guidance from the World Health Organization (WHO) recommending lenacapavir as an additional pre-exposure prophylaxis (PrEP) option. Administered twice yearly, lenacapavir represents a departure from daily oral regimens and…